We are live on ! Find out more

399 hedge funds and large institutions have $16.5B invested in Incyte in 2016 Q3 according to their latest regulatory filings, with 62 funds opening new positions, 142 increasing their positions, 136 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% more first-time investments, than exits

New positions opened: 62 | Existing positions closed: 32

63% more funds holding in top 10

Funds holding in top 10: 813 (+5)

34% more call options, than puts

Call options by funds: $117M | Put options by funds: $87.2M

18% more capital invested

Capital invested by funds: $14B → $16.5B (+$2.46B)

8% more funds holding

Funds holding: 371399 (+28)

4% more repeat investments, than reductions

Existing positions increased: 142 | Existing positions reduced: 136

Holders
399
Holders Change
+28
Holders Change %
+7.55%
% of All Funds
10.61%
Holding in Top 10
13
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+62.5%
% of All Funds
0.35%
New
62
Increased
142
Reduced
136
Closed
32
Calls
$117M
Puts
$87.2M
Net Calls
+$29.9M
Net Calls Change
+$7.03M

INCY Hedge Fund Activity: Q3 2016 in Review

399 of the 3,759 institutional investors tracked by Wall St. Rank reported a position in Incyte (INCY) for Q3 2016, worth a combined $16.5B — up 18% from $14B a quarter earlier.

Buyers outnumbered sellers: 62 funds opened new INCY positions and 32 closed out — a net gain of 30 holders — while 142 added to existing stakes and 136 trimmed.

The largest buyer was Matrix Capital Management Company, adding an estimated $67.4M. The largest seller was T. Rowe Price Associates, cutting an estimated $136M.

  • 399 institutional investors held Incyte (INCY) as of Q3 2016, up from 371 in Q2 2016.
  • Funds reported $16.5B of Incyte stock for Q3 2016, up 18% quarter-over-quarter.
  • 62 funds opened new Incyte positions in Q3 2016 and 32 closed out, a net change of +30 holders.
  • The largest Incyte buyer in Q3 2016 was Matrix Capital Management Company, an estimated $67.4M added.
  • The largest Incyte seller in Q3 2016 was T. Rowe Price Associates, an estimated $136M sold.

Based on aggregated 13F filings for Q3 2016.